LLY
Eli Lilly and Company
LLY has the edge over OSUR overall, supported by stronger fundamentals and stronger modeled upside.
OSUR
OraSure Technologies, Inc.
OSUR's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
OSUR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
OSUR's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
OSUR PE Valuation
OSUR has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
OSUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect OSUR's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over OSUR on earnings quality, reporting a profit while its opponent remains loss making.
OSUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.70 | +$0.10 |
| Q2 2026 | -$0.70 | -$0.03 |
| Q1 2026 | -$1.05 | -$0.63 |
| Q4 2025 | -$0.94 | -$0.68 |
| Q3 2025 | -$0.80 | -633% |
| Q2 2025 | -$0.67 | -286% |
| Q1 2025 | -$0.42 | -240% |
| Q4 2024 | -$0.26 | -136% |
OSUR lost $0.70 per share over the past year, a smaller loss than the year before.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over OSUR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over OSUR on profitability, with a higher operating margin.
OSUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.9M | +14% |
| Q2 2026 | $30.6M | -1.9% |
| Q1 2026 | $27.9M | -6.7% |
| Q4 2025 | $26.8M | -29% |
| Q3 2025 | $27.1M | -32% |
| Q2 2025 | $31.2M | -43% |
| Q1 2025 | $29.9M | -45% |
| Q4 2024 | $37.4M | -51% |
OSUR's revenue is recovering but still below its 2023 peak: $31M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -42% | +18 points |
| Q2 2026 | 18% | +76 points |
| Q1 2026 | -83% | -24 points |
| Q4 2025 | -75% | -42 points |
| Q3 2025 | -59% | -44 points |
| Q2 2025 | -58% | -53 points |
| Q1 2025 | -59% | -46 points |
| Q4 2024 | -33% | -38 points |
OSUR's operating margin was −42% last quarter, up 17 points from the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over OSUR on cash generation, producing positive trailing cash flow while its opponent burns cash.
OSUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$12.5M | -$1.6M |
| Q2 2026 | -$12.3M | -$190K |
| Q1 2026 | -$14.8M | +$5.3M |
| Q4 2025 | -$9.9M | -$9.6M |
| Q3 2025 | -$11M | -188% |
| Q2 2025 | -$12.2M | -295% |
| Q1 2025 | -$20.2M | -491% |
| Q4 2024 | -$347K | -101% |
OSUR has burned cash in most quarters: −$50M over the past year, against −$44M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
OSUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -1.2M shares |
| 1 year | -5.5% | -4M shares |
| 3 years | -7.2% | -5.3M shares |
| 5 years | -4.2% | -3M shares |
| Available history | +11% | +6.8M shares |
OSUR has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | $5M |
| Q4 2025 | $5M |
| Q3 2025 | $5M |
| Q2 2025 | $4.1M |
| Q1 2025 | $941,000 |
| Q4 2024 | $15,000 |
OSUR spent $12M buying back its own shares over the past year, up 20% from the year before.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
OSUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -27,857.1x | Net Cash |
| Q2 2024 | -15.0x | Net Cash |
| Q1 2024 | -11.6x | Net Cash |
| Q4 2023 | -5.4x | Net Cash |
| Q3 2023 | -3.4x | Net Cash |
| Q2 2023 | -3.4x | Net Cash |
| Q1 2023 | -2.8x | Net Cash |
| Q4 2021 | -78.2x | Net Cash |
OSUR has more cash than debt.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
OSUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 42.0 | Neutral |
OSUR's weekly RSI is 49 (neutral) and its Stochastic is 42 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
OSUR PE vs Healthcare Sector
| Metric | OSUR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
OSUR has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over OSUR on trend strength, trading above more of its moving averages.
OSUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.82 | 5.2% below |
| 20 week MA | $3.84 | 5.7% below |
| 50 week MA | $3.38 | 7.1% above |
| 100 week MA | $3.26 | 11% above |
| 200 week MA | $4.43 | 18% below |
OSUR's trend is mixed: it's above two of its five weekly moving averages, and 18% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
OSUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.92 | $11.6 | +46% |
| 2021 | $11.6 | $9.25 | -20% |
| 2022 | $9.25 | $4.73 | -49% |
| 2023 | $4.73 | $8.20 | +73% |
| 2024 | $8.20 | $3.62 | -56% |
| 2025 | $3.62 | $2.42 | -33% |
| 2026 YTD | $2.42 | $3.62 | +50% |
OSUR has the edge over LLY on returns for 2026, with the stronger performance.